Knowledge hub

Join us here for a closer look at the news, research and trends shaping the diagnostic landscape.

‍

‍

‍

‍

Knowledge hub

Join us here for a closer look at the news, research and trends shaping the diagnostic landscape.

‍

‍

‍

‍

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Changing needs for thalassemia testing and how it will impact clinical labs

What you need to know about thalassemia prevalence and the implications for clinical laboratories.

Tips and tricks

Sequence planning

Devyser offers an online Sequence Coverage Calculator to help plan your NGS run for optimal results.

About Thalassemia

Thalassemias are haemoglobinopathies characterised by an abnormal haemoglobin production that can lead to anaemia and destruction of red blood cells.

Rapid aneuploidy analysis

Thrombophilia an important factor in thrombosis risk

Every year world thrombosis day is held on October 13 to bring awareness to the potential risks of developing thrombisis.

NGS identification of both male and female cancer risks

Do you know a man who has participated at least once in “Movember”?

CRISPR Helps BRCA1 Researchers Determine Functional And Non-Functional Mutations

BRCA1 variants may generally be divided into three categories: benign variants, which cause no clinical concern; deleterious variants

CRISPR-Cas9 presents new possibilities for Thalassemia treatment.

The autosomal recessive inherited blood disorder, b-thalassemia, is caused by reduced or absent synthesis of the beta chains of hemoglobin due to mutations

Cystic fibrosis

Clinical trials highlight the importance of correct CFTR mutation detection in cystic fibrosis patients

Cystic Fibrosis is one of the most common genetic disorders.

Experts Recommend FH Genetic Testing

An expert consensus panel has recently promoted genetic testing for Familial Hypercholesterolemia (FH) as a standard of care for patients with probable FH

New Devyser BRCA NGS study published

In this study, the Devyser BRCA test was used to analyse 227 patient DNA samples.

Rapid aneuploidy analysis

No Significant Reduction in Miscarriage Rates from NIPT Pre-Screening for Trisomy 21 as compared to invasive testing

A recent paper published by Malan et al in the Journal of the American Medical Association (JAMA) describes a clinical study

Robust NGS workflow provides full BRCA1 & BRCA2 screening

The team at Devyser were excited to see our products put to use in a recent research project